nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—CXCL8—atopic dermatitis	0.387	1	CbGaD
Tolmetin—osteoarthritis—Methylprednisolone—atopic dermatitis	0.188	0.5	CpDpCtD
Tolmetin—osteoarthritis—Prednisone—atopic dermatitis	0.188	0.5	CpDpCtD
Tolmetin—PTGS1—Diphenhydramine—atopic dermatitis	0.0447	0.341	CbGbCtD
Tolmetin—PTGS2—Triamcinolone—atopic dermatitis	0.0367	0.28	CbGbCtD
Tolmetin—PTGS2—Betamethasone—atopic dermatitis	0.0315	0.24	CbGbCtD
Tolmetin—PTGS2—Dexamethasone—atopic dermatitis	0.0183	0.14	CbGbCtD
Tolmetin—Blood pressure increased—Desonide—atopic dermatitis	0.0013	0.0247	CcSEcCtD
Tolmetin—Skin irritation—Tacrolimus—atopic dermatitis	0.00115	0.0219	CcSEcCtD
Tolmetin—Indomethacin—PPARA—atopic dermatitis	0.00086	0.591	CrCbGaD
Tolmetin—Haemolytic anaemia—Dimenhydrinate—atopic dermatitis	0.000761	0.0145	CcSEcCtD
Tolmetin—Haemolytic anaemia—Diphenhydramine—atopic dermatitis	0.000761	0.0145	CcSEcCtD
Tolmetin—Skin irritation—Hydrocortisone—atopic dermatitis	0.000718	0.0137	CcSEcCtD
Tolmetin—Indomethacin—CXCL8—atopic dermatitis	0.000596	0.409	CrCbGaD
Tolmetin—Proteinuria—Tacrolimus—atopic dermatitis	0.000567	0.0108	CcSEcCtD
Tolmetin—Protein urine present—Tacrolimus—atopic dermatitis	0.000559	0.0107	CcSEcCtD
Tolmetin—Dysuria—Dimenhydrinate—atopic dermatitis	0.000555	0.0106	CcSEcCtD
Tolmetin—Dysuria—Diphenhydramine—atopic dermatitis	0.000555	0.0106	CcSEcCtD
Tolmetin—Drowsiness—Diphenhydramine—atopic dermatitis	0.00053	0.0101	CcSEcCtD
Tolmetin—Drowsiness—Dimenhydrinate—atopic dermatitis	0.00053	0.0101	CcSEcCtD
Tolmetin—Visual disturbance—Fluocinolone Acetonide—atopic dermatitis	0.000502	0.00957	CcSEcCtD
Tolmetin—Agranulocytosis—Dimenhydrinate—atopic dermatitis	0.000494	0.00942	CcSEcCtD
Tolmetin—Agranulocytosis—Diphenhydramine—atopic dermatitis	0.000494	0.00942	CcSEcCtD
Tolmetin—Epistaxis—Pimecrolimus—atopic dermatitis	0.000483	0.00921	CcSEcCtD
Tolmetin—Blood urea increased—Tacrolimus—atopic dermatitis	0.00047	0.00896	CcSEcCtD
Tolmetin—Gastritis—Loratadine—atopic dermatitis	0.000468	0.00893	CcSEcCtD
Tolmetin—Tinnitus—Dimenhydrinate—atopic dermatitis	0.000443	0.00845	CcSEcCtD
Tolmetin—Tinnitus—Diphenhydramine—atopic dermatitis	0.000443	0.00845	CcSEcCtD
Tolmetin—Lymphadenopathy—Tacrolimus—atopic dermatitis	0.000424	0.00808	CcSEcCtD
Tolmetin—PTGS2—Fluocinonide—Desonide—atopic dermatitis	0.000418	0.165	CbGdCrCtD
Tolmetin—Drowsiness—Loratadine—atopic dermatitis	0.000408	0.00777	CcSEcCtD
Tolmetin—Haemolytic anaemia—Tacrolimus—atopic dermatitis	0.000401	0.00763	CcSEcCtD
Tolmetin—Cardiac failure congestive—Tacrolimus—atopic dermatitis	0.000399	0.0076	CcSEcCtD
Tolmetin—Epistaxis—Loratadine—atopic dermatitis	0.000385	0.00733	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Tacrolimus—atopic dermatitis	0.000374	0.00712	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Tacrolimus—atopic dermatitis	0.000362	0.00689	CcSEcCtD
Tolmetin—Tinnitus—Loratadine—atopic dermatitis	0.000341	0.00651	CcSEcCtD
Tolmetin—Urinary tract infection—Mometasone—atopic dermatitis	0.00034	0.00648	CcSEcCtD
Tolmetin—Thrombocytopenia—Dimenhydrinate—atopic dermatitis	0.000331	0.0063	CcSEcCtD
Tolmetin—Thrombocytopenia—Diphenhydramine—atopic dermatitis	0.000331	0.0063	CcSEcCtD
Tolmetin—Epistaxis—Mometasone—atopic dermatitis	0.00033	0.00629	CcSEcCtD
Tolmetin—Oedema—Pimecrolimus—atopic dermatitis	0.000327	0.00622	CcSEcCtD
Tolmetin—Anaphylactic shock—Pimecrolimus—atopic dermatitis	0.000327	0.00622	CcSEcCtD
Tolmetin—PTGS2—Fluocinonide—Fluocinolone Acetonide—atopic dermatitis	0.000326	0.128	CbGdCrCtD
Tolmetin—Toxic epidermal necrolysis—Tacrolimus—atopic dermatitis	0.000326	0.0062	CcSEcCtD
Tolmetin—Gastritis—Tacrolimus—atopic dermatitis	0.00032	0.0061	CcSEcCtD
Tolmetin—Visual impairment—Fluocinolone Acetonide—atopic dermatitis	0.000317	0.00604	CcSEcCtD
Tolmetin—Somnolence—Dimenhydrinate—atopic dermatitis	0.0003	0.00572	CcSEcCtD
Tolmetin—Somnolence—Diphenhydramine—atopic dermatitis	0.0003	0.00572	CcSEcCtD
Tolmetin—Dyspepsia—Dimenhydrinate—atopic dermatitis	0.000297	0.00567	CcSEcCtD
Tolmetin—Dyspepsia—Diphenhydramine—atopic dermatitis	0.000297	0.00567	CcSEcCtD
Tolmetin—Dysuria—Tacrolimus—atopic dermatitis	0.000292	0.00557	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL5—atopic dermatitis	0.000292	0.00592	CbGpPWpGaD
Tolmetin—CXCL8—Chemokine receptors bind chemokines—CCL5—atopic dermatitis	0.00029	0.0059	CbGpPWpGaD
Tolmetin—Headache—Desonide—atopic dermatitis	0.00029	0.00552	CcSEcCtD
Tolmetin—Constipation—Dimenhydrinate—atopic dermatitis	0.000289	0.00551	CcSEcCtD
Tolmetin—Constipation—Diphenhydramine—atopic dermatitis	0.000289	0.00551	CcSEcCtD
Tolmetin—MPO—IL23-mediated signaling events—IL1B—atopic dermatitis	0.000285	0.00579	CbGpPWpGaD
Tolmetin—Weight increased—Tacrolimus—atopic dermatitis	0.000284	0.00542	CcSEcCtD
Tolmetin—MPO—IL23-mediated signaling events—IL2—atopic dermatitis	0.000284	0.00577	CbGpPWpGaD
Tolmetin—CXCL8—EBV LMP1 signaling—MAPK8—atopic dermatitis	0.000283	0.00576	CbGpPWpGaD
Tolmetin—Weight decreased—Tacrolimus—atopic dermatitis	0.000283	0.00539	CcSEcCtD
Tolmetin—Constipation—Pimecrolimus—atopic dermatitis	0.000279	0.00532	CcSEcCtD
Tolmetin—Renal failure—Tacrolimus—atopic dermatitis	0.000274	0.00522	CcSEcCtD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.000273	0.00555	CbGpPWpGaD
Tolmetin—Stomatitis—Tacrolimus—atopic dermatitis	0.000272	0.00518	CcSEcCtD
Tolmetin—Chest pain—Loratadine—atopic dermatitis	0.000271	0.00517	CcSEcCtD
Tolmetin—Urinary tract infection—Tacrolimus—atopic dermatitis	0.000271	0.00516	CcSEcCtD
Tolmetin—Urticaria—Diphenhydramine—atopic dermatitis	0.000268	0.00511	CcSEcCtD
Tolmetin—Urticaria—Dimenhydrinate—atopic dermatitis	0.000268	0.00511	CcSEcCtD
Tolmetin—Gastrointestinal pain—Pimecrolimus—atopic dermatitis	0.000267	0.00509	CcSEcCtD
Tolmetin—Haematuria—Tacrolimus—atopic dermatitis	0.000266	0.00506	CcSEcCtD
Tolmetin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—atopic dermatitis	0.000265	0.00538	CbGpPWpGaD
Tolmetin—Epistaxis—Tacrolimus—atopic dermatitis	0.000263	0.00501	CcSEcCtD
Tolmetin—CXCL8—Chemokine receptors bind chemokines—CCR5—atopic dermatitis	0.000262	0.00531	CbGpPWpGaD
Tolmetin—CXCL8—Overview of nanoparticle effects—TNF—atopic dermatitis	0.000261	0.00531	CbGpPWpGaD
Tolmetin—Anaphylactic shock—Loratadine—atopic dermatitis	0.00026	0.00496	CcSEcCtD
Tolmetin—Agranulocytosis—Tacrolimus—atopic dermatitis	0.00026	0.00496	CcSEcCtD
Tolmetin—PTGS2—Fluocinonide—Mometasone—atopic dermatitis	0.00026	0.102	CbGdCrCtD
Tolmetin—Urticaria—Pimecrolimus—atopic dermatitis	0.000259	0.00495	CcSEcCtD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—atopic dermatitis	0.000259	0.00527	CbGpPWpGaD
Tolmetin—Abdominal pain—Pimecrolimus—atopic dermatitis	0.000258	0.00492	CcSEcCtD
Tolmetin—Body temperature increased—Pimecrolimus—atopic dermatitis	0.000258	0.00492	CcSEcCtD
Tolmetin—CXCL8—G alpha (i) signalling events—CCL27—atopic dermatitis	0.000257	0.00522	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—NFKBIA—atopic dermatitis	0.000255	0.00518	CbGpPWpGaD
Tolmetin—Cardiac failure congestive—Prednisolone—atopic dermatitis	0.000255	0.00485	CcSEcCtD
Tolmetin—Hepatitis—Tacrolimus—atopic dermatitis	0.00025	0.00477	CcSEcCtD
Tolmetin—Cardiac failure congestive—Hydrocortisone—atopic dermatitis	0.000249	0.00474	CcSEcCtD
Tolmetin—Dizziness—Fluocinonide—atopic dermatitis	0.000248	0.00472	CcSEcCtD
Tolmetin—MPO—Vitamin B12 Metabolism—IFNG—atopic dermatitis	0.000247	0.00502	CbGpPWpGaD
Tolmetin—Visual disturbance—Prednisolone—atopic dermatitis	0.000244	0.00464	CcSEcCtD
Tolmetin—Asthenia—Diphenhydramine—atopic dermatitis	0.000242	0.00462	CcSEcCtD
Tolmetin—Asthenia—Dimenhydrinate—atopic dermatitis	0.000242	0.00462	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—IL10—atopic dermatitis	0.000242	0.00492	CbGpPWpGaD
Tolmetin—Visual impairment—Tacrolimus—atopic dermatitis	0.000241	0.00459	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Prednisolone—atopic dermatitis	0.000239	0.00455	CcSEcCtD
Tolmetin—Vascular purpura—Triamcinolone—atopic dermatitis	0.000237	0.00452	CcSEcCtD
Tolmetin—Erythema multiforme—Tacrolimus—atopic dermatitis	0.000237	0.00451	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—IL4—atopic dermatitis	0.000235	0.00478	CbGpPWpGaD
Tolmetin—Headache—Fluocinonide—atopic dermatitis	0.000235	0.00447	CcSEcCtD
Tolmetin—Cardiac failure congestive—Triamcinolone—atopic dermatitis	0.000234	0.00446	CcSEcCtD
Tolmetin—Oedema—Fluocinolone Acetonide—atopic dermatitis	0.000234	0.00446	CcSEcCtD
Tolmetin—Cardiac failure congestive—Methylprednisolone—atopic dermatitis	0.000234	0.00445	CcSEcCtD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TLR2—atopic dermatitis	0.000234	0.00475	CbGpPWpGaD
Tolmetin—Tinnitus—Tacrolimus—atopic dermatitis	0.000233	0.00444	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Hydrocortisone—atopic dermatitis	0.000233	0.00444	CcSEcCtD
Tolmetin—Chest pain—Mometasone—atopic dermatitis	0.000233	0.00444	CcSEcCtD
Tolmetin—Somnolence—Loratadine—atopic dermatitis	0.000231	0.00441	CcSEcCtD
Tolmetin—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.000231	0.0044	CcSEcCtD
Tolmetin—Diarrhoea—Diphenhydramine—atopic dermatitis	0.000231	0.0044	CcSEcCtD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.000229	0.00466	CbGpPWpGaD
Tolmetin—Dyspepsia—Loratadine—atopic dermatitis	0.000229	0.00436	CcSEcCtD
Tolmetin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	0.000227	0.00462	CbGpPWpGaD
Tolmetin—CXCL8—EBV LMP1 signaling—TNF—atopic dermatitis	0.000224	0.00456	CbGpPWpGaD
Tolmetin—Diarrhoea—Pimecrolimus—atopic dermatitis	0.000223	0.00426	CcSEcCtD
Tolmetin—CXCL8—Cellular responses to stress—CABIN1—atopic dermatitis	0.000223	0.00454	CbGpPWpGaD
Tolmetin—Dizziness—Dimenhydrinate—atopic dermatitis	0.000223	0.00426	CcSEcCtD
Tolmetin—Dizziness—Diphenhydramine—atopic dermatitis	0.000223	0.00426	CcSEcCtD
Tolmetin—Anaphylactic shock—Mometasone—atopic dermatitis	0.000223	0.00425	CcSEcCtD
Tolmetin—Constipation—Loratadine—atopic dermatitis	0.000222	0.00424	CcSEcCtD
Tolmetin—MPO—Vitamin B12 Metabolism—IL1B—atopic dermatitis	0.00022	0.00448	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.00022	0.00448	CbGpPWpGaD
Tolmetin—Purpura—Triamcinolone—atopic dermatitis	0.00022	0.0042	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—IL10—atopic dermatitis	0.00022	0.00446	CbGpPWpGaD
Tolmetin—Anaphylactoid reaction—Triamcinolone—atopic dermatitis	0.000219	0.00418	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Methylprednisolone—atopic dermatitis	0.000219	0.00417	CcSEcCtD
Tolmetin—Vomiting—Diphenhydramine—atopic dermatitis	0.000215	0.00409	CcSEcCtD
Tolmetin—Vomiting—Dimenhydrinate—atopic dermatitis	0.000215	0.00409	CcSEcCtD
Tolmetin—Flatulence—Tacrolimus—atopic dermatitis	0.000215	0.00409	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—IL4—atopic dermatitis	0.000214	0.00434	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Loratadine—atopic dermatitis	0.000213	0.00405	CcSEcCtD
Tolmetin—Cardiac failure congestive—Betamethasone—atopic dermatitis	0.000212	0.00405	CcSEcCtD
Tolmetin—Cardiac failure congestive—Dexamethasone—atopic dermatitis	0.000212	0.00405	CcSEcCtD
Tolmetin—Headache—Diphenhydramine—atopic dermatitis	0.000212	0.00403	CcSEcCtD
Tolmetin—Headache—Dimenhydrinate—atopic dermatitis	0.000212	0.00403	CcSEcCtD
Tolmetin—CXCL8—Overview of nanoparticle effects—IL6—atopic dermatitis	0.000211	0.00428	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—CXCL10—atopic dermatitis	0.000209	0.00424	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—atopic dermatitis	0.000209	0.00424	CbGpPWpGaD
Tolmetin—Vomiting—Pimecrolimus—atopic dermatitis	0.000208	0.00396	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL4—atopic dermatitis	0.000207	0.00421	CbGpPWpGaD
Tolmetin—PTGS1—Overview of nanoparticle effects—CXCL8—atopic dermatitis	0.000207	0.00421	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—TNF—atopic dermatitis	0.000207	0.0042	CbGpPWpGaD
Tolmetin—Body temperature increased—Loratadine—atopic dermatitis	0.000206	0.00392	CcSEcCtD
Tolmetin—Abdominal pain—Loratadine—atopic dermatitis	0.000206	0.00392	CcSEcCtD
Tolmetin—Headache—Pimecrolimus—atopic dermatitis	0.000205	0.0039	CcSEcCtD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000204	0.00415	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL13—atopic dermatitis	0.000204	0.00414	CbGpPWpGaD
Tolmetin—Visual disturbance—Betamethasone—atopic dermatitis	0.000203	0.00388	CcSEcCtD
Tolmetin—Visual disturbance—Dexamethasone—atopic dermatitis	0.000203	0.00388	CcSEcCtD
Tolmetin—PTGS2—Fluticasone Propionate—Fluocinonide—atopic dermatitis	0.000202	0.0797	CbGdCrCtD
Tolmetin—MPO—Folate Metabolism—IFNG—atopic dermatitis	0.000201	0.00408	CbGpPWpGaD
Tolmetin—Nausea—Diphenhydramine—atopic dermatitis	0.000201	0.00382	CcSEcCtD
Tolmetin—Nausea—Dimenhydrinate—atopic dermatitis	0.000201	0.00382	CcSEcCtD
Tolmetin—CXCL8—LPA receptor mediated events—NFKBIA—atopic dermatitis	0.000199	0.00405	CbGpPWpGaD
Tolmetin—Anaphylactoid reaction—Dexamethasone—atopic dermatitis	0.000199	0.00379	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Betamethasone—atopic dermatitis	0.000199	0.00379	CcSEcCtD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—MAPK8—atopic dermatitis	0.000198	0.00402	CbGpPWpGaD
Tolmetin—Dyspepsia—Mometasone—atopic dermatitis	0.000197	0.00375	CcSEcCtD
Tolmetin—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—atopic dermatitis	0.000197	0.0774	CbGdCrCtD
Tolmetin—CXCL8—Corticotropin-releasing hormone—IL18—atopic dermatitis	0.000195	0.00397	CbGpPWpGaD
Tolmetin—Nausea—Pimecrolimus—atopic dermatitis	0.000194	0.0037	CcSEcCtD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—atopic dermatitis	0.00019	0.00385	CbGpPWpGaD
Tolmetin—Vascular purpura—Prednisone—atopic dermatitis	0.000188	0.00357	CcSEcCtD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—TAC1—atopic dermatitis	0.000187	0.00381	CbGpPWpGaD
Tolmetin—Asthenia—Loratadine—atopic dermatitis	0.000187	0.00356	CcSEcCtD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—atopic dermatitis	0.000186	0.00378	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—CXCL10—atopic dermatitis	0.000186	0.00377	CbGpPWpGaD
Tolmetin—Chest pain—Tacrolimus—atopic dermatitis	0.000185	0.00353	CcSEcCtD
Tolmetin—Cardiac failure congestive—Prednisone—atopic dermatitis	0.000185	0.00353	CcSEcCtD
Tolmetin—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.000185	0.00352	CcSEcCtD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000183	0.00373	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000183	0.00348	CcSEcCtD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TLR2—atopic dermatitis	0.000182	0.0037	CbGpPWpGaD
Tolmetin—Weight increased—Prednisolone—atopic dermatitis	0.000182	0.00346	CcSEcCtD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—CCL5—atopic dermatitis	0.00018	0.00365	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.00018	0.00365	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—IL1B—atopic dermatitis	0.000179	0.00364	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—IL2—atopic dermatitis	0.000179	0.00363	CbGpPWpGaD
Tolmetin—Diarrhoea—Loratadine—atopic dermatitis	0.000178	0.00339	CcSEcCtD
Tolmetin—Oedema—Tacrolimus—atopic dermatitis	0.000178	0.00339	CcSEcCtD
Tolmetin—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.000178	0.00339	CcSEcCtD
Tolmetin—Weight increased—Hydrocortisone—atopic dermatitis	0.000177	0.00338	CcSEcCtD
Tolmetin—Body temperature increased—Mometasone—atopic dermatitis	0.000177	0.00336	CcSEcCtD
Tolmetin—Abdominal pain—Mometasone—atopic dermatitis	0.000177	0.00336	CcSEcCtD
Tolmetin—Weight decreased—Hydrocortisone—atopic dermatitis	0.000176	0.00336	CcSEcCtD
Tolmetin—CXCL8—GPCR ligand binding—CCL22—atopic dermatitis	0.000175	0.00355	CbGpPWpGaD
Tolmetin—Purpura—Prednisone—atopic dermatitis	0.000174	0.00332	CcSEcCtD
Tolmetin—Thrombocytopenia—Tacrolimus—atopic dermatitis	0.000174	0.00332	CcSEcCtD
Tolmetin—Dizziness—Loratadine—atopic dermatitis	0.000172	0.00328	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Prednisone—atopic dermatitis	0.000168	0.0032	CcSEcCtD
Tolmetin—Weight increased—Triamcinolone—atopic dermatitis	0.000167	0.00318	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—BDNF—atopic dermatitis	0.000167	0.00339	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—IL6—atopic dermatitis	0.000167	0.00339	CbGpPWpGaD
Tolmetin—Weight increased—Methylprednisolone—atopic dermatitis	0.000167	0.00318	CcSEcCtD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—atopic dermatitis	0.000165	0.00336	CbGpPWpGaD
Tolmetin—Vomiting—Loratadine—atopic dermatitis	0.000165	0.00315	CcSEcCtD
Tolmetin—PTGS2—Overview of nanoparticle effects—CXCL8—atopic dermatitis	0.000164	0.00334	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—IFNG—atopic dermatitis	0.000163	0.00331	CbGpPWpGaD
Tolmetin—Headache—Loratadine—atopic dermatitis	0.000163	0.00311	CcSEcCtD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—CXCL10—atopic dermatitis	0.000163	0.00331	CbGpPWpGaD
Tolmetin—Asthenia—Mometasone—atopic dermatitis	0.00016	0.00305	CcSEcCtD
Tolmetin—MPO—C-MYB transcription factor network—CD4—atopic dermatitis	0.00016	0.00325	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00016	0.00325	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00016	0.00325	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—MAPK8—atopic dermatitis	0.00016	0.00325	CbGpPWpGaD
Tolmetin—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.00016	0.00305	CcSEcCtD
Tolmetin—MPO—Vitamin B12 Metabolism—TNF—atopic dermatitis	0.00016	0.00325	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.00016	0.00325	CbGpPWpGaD
Tolmetin—Somnolence—Tacrolimus—atopic dermatitis	0.000158	0.00301	CcSEcCtD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000157	0.00319	CbGpPWpGaD
Tolmetin—PTGS2—Fluticasone Propionate—Mometasone—atopic dermatitis	0.000157	0.0618	CbGdCrCtD
Tolmetin—Dyspepsia—Tacrolimus—atopic dermatitis	0.000156	0.00298	CcSEcCtD
Tolmetin—CXCL8—GPCR ligand binding—CCL27—atopic dermatitis	0.000156	0.00316	CbGpPWpGaD
Tolmetin—PTGS2—Fluocinonide—Methylprednisolone—atopic dermatitis	0.000155	0.0612	CbGdCrCtD
Tolmetin—CXCL8—Spinal Cord Injury—IL4—atopic dermatitis	0.000155	0.00315	CbGpPWpGaD
Tolmetin—CXCL8—IL-3 Signaling Pathway—MAPK8—atopic dermatitis	0.000155	0.00314	CbGpPWpGaD
Tolmetin—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000155	0.00295	CcSEcCtD
Tolmetin—Nausea—Loratadine—atopic dermatitis	0.000155	0.00295	CcSEcCtD
Tolmetin—Epistaxis—Triamcinolone—atopic dermatitis	0.000154	0.00294	CcSEcCtD
Tolmetin—Visual impairment—Prednisolone—atopic dermatitis	0.000154	0.00293	CcSEcCtD
Tolmetin—Diarrhoea—Mometasone—atopic dermatitis	0.000153	0.00291	CcSEcCtD
Tolmetin—PTGS2—Fluocinonide—Betamethasone—atopic dermatitis	0.000153	0.0602	CbGdCrCtD
Tolmetin—PTGS2—Fluocinonide—Dexamethasone—atopic dermatitis	0.000153	0.0602	CbGdCrCtD
Tolmetin—Constipation—Tacrolimus—atopic dermatitis	0.000152	0.0029	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—CASP8—atopic dermatitis	0.000152	0.00309	CbGpPWpGaD
Tolmetin—Weight increased—Dexamethasone—atopic dermatitis	0.000152	0.00289	CcSEcCtD
Tolmetin—Weight increased—Betamethasone—atopic dermatitis	0.000152	0.00289	CcSEcCtD
Tolmetin—CXCL8—G alpha (i) signalling events—CCR3—atopic dermatitis	0.000152	0.00308	CbGpPWpGaD
Tolmetin—Weight decreased—Betamethasone—atopic dermatitis	0.000151	0.00287	CcSEcCtD
Tolmetin—Weight decreased—Dexamethasone—atopic dermatitis	0.000151	0.00287	CcSEcCtD
Tolmetin—PTGS2—Fluocinonide—Triamcinolone—atopic dermatitis	0.000149	0.0588	CbGdCrCtD
Tolmetin—CXCL8—Corticotropin-releasing hormone—NFKBIA—atopic dermatitis	0.000149	0.00303	CbGpPWpGaD
Tolmetin—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000149	0.00283	CcSEcCtD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000148	0.003	CbGpPWpGaD
Tolmetin—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000146	0.00279	CcSEcCtD
Tolmetin—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000145	0.00277	CcSEcCtD
Tolmetin—PTGS1—Overview of nanoparticle effects—TNF—atopic dermatitis	0.000144	0.00293	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000143	0.00291	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—IL1B—atopic dermatitis	0.000142	0.00289	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—IFNG—atopic dermatitis	0.000142	0.00289	CbGpPWpGaD
Tolmetin—Vomiting—Mometasone—atopic dermatitis	0.000142	0.00271	CcSEcCtD
Tolmetin—Visual impairment—Methylprednisolone—atopic dermatitis	0.000141	0.00269	CcSEcCtD
Tolmetin—Urticaria—Tacrolimus—atopic dermatitis	0.000141	0.00269	CcSEcCtD
Tolmetin—Body temperature increased—Tacrolimus—atopic dermatitis	0.00014	0.00268	CcSEcCtD
Tolmetin—Abdominal pain—Tacrolimus—atopic dermatitis	0.00014	0.00268	CcSEcCtD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—CCL5—atopic dermatitis	0.00014	0.00285	CbGpPWpGaD
Tolmetin—Headache—Mometasone—atopic dermatitis	0.00014	0.00267	CcSEcCtD
Tolmetin—CXCL8—GPCR ligand binding—CCL17—atopic dermatitis	0.00014	0.00284	CbGpPWpGaD
Tolmetin—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000139	0.00265	CcSEcCtD
Tolmetin—TDO2—Metabolism—GLB1—atopic dermatitis	0.000138	0.00281	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—NFKBIA—atopic dermatitis	0.000137	0.00279	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—atopic dermatitis	0.000135	0.00274	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—BDNF—atopic dermatitis	0.000133	0.00271	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—MAPK8—atopic dermatitis	0.000133	0.00271	CbGpPWpGaD
Tolmetin—Nausea—Mometasone—atopic dermatitis	0.000133	0.00253	CcSEcCtD
Tolmetin—TDO2—Metabolism—ADSL—atopic dermatitis	0.000133	0.00269	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000132	0.00269	CbGpPWpGaD
Tolmetin—Weight increased—Prednisone—atopic dermatitis	0.000132	0.00252	CcSEcCtD
Tolmetin—Weight decreased—Prednisone—atopic dermatitis	0.000131	0.0025	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—TNF—atopic dermatitis	0.00013	0.00264	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IFNG—atopic dermatitis	0.000129	0.00262	CbGpPWpGaD
Tolmetin—MPO—Vitamin B12 Metabolism—IL6—atopic dermatitis	0.000129	0.00262	CbGpPWpGaD
Tolmetin—Visual impairment—Dexamethasone—atopic dermatitis	0.000128	0.00245	CcSEcCtD
Tolmetin—Visual impairment—Betamethasone—atopic dermatitis	0.000128	0.00245	CcSEcCtD
Tolmetin—Asthenia—Tacrolimus—atopic dermatitis	0.000128	0.00243	CcSEcCtD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL10—atopic dermatitis	0.000127	0.00259	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000127	0.00258	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—IL2—atopic dermatitis	0.000126	0.00257	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—atopic dermatitis	0.000126	0.00256	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IFNG—atopic dermatitis	0.000125	0.00255	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—CASP8—atopic dermatitis	0.000124	0.00252	CbGpPWpGaD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—atopic dermatitis	0.000124	0.00251	CbGpPWpGaD
Tolmetin—Diarrhoea—Tacrolimus—atopic dermatitis	0.000122	0.00232	CcSEcCtD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—atopic dermatitis	0.000121	0.00245	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00012	0.00245	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—NGF—atopic dermatitis	0.000118	0.00241	CbGpPWpGaD
Tolmetin—Dizziness—Tacrolimus—atopic dermatitis	0.000118	0.00224	CcSEcCtD
Tolmetin—PTGS1—Overview of nanoparticle effects—IL6—atopic dermatitis	0.000116	0.00236	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IL1B—atopic dermatitis	0.000115	0.00234	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IL2—atopic dermatitis	0.000115	0.00233	CbGpPWpGaD
Tolmetin—PTGS2—Overview of nanoparticle effects—TNF—atopic dermatitis	0.000114	0.00233	CbGpPWpGaD
Tolmetin—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000114	0.00216	CcSEcCtD
Tolmetin—Oedema—Prednisolone—atopic dermatitis	0.000114	0.00216	CcSEcCtD
Tolmetin—Vomiting—Tacrolimus—atopic dermatitis	0.000113	0.00215	CcSEcCtD
Tolmetin—CXCL8—GPCR ligand binding—CCL11—atopic dermatitis	0.000113	0.00229	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—atopic dermatitis	0.000112	0.00228	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL2—atopic dermatitis	0.000111	0.00226	CbGpPWpGaD
Tolmetin—Headache—Tacrolimus—atopic dermatitis	0.000111	0.00212	CcSEcCtD
Tolmetin—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000111	0.00211	CcSEcCtD
Tolmetin—Oedema—Hydrocortisone—atopic dermatitis	0.000111	0.00211	CcSEcCtD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000109	0.00222	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000107	0.00218	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000107	0.00218	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—NFKBIA—atopic dermatitis	0.000107	0.00218	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000107	0.00218	CbGpPWpGaD
Tolmetin—Nausea—Tacrolimus—atopic dermatitis	0.000106	0.00201	CcSEcCtD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000105	0.00214	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—IL6—atopic dermatitis	0.000105	0.00213	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—GLB1—atopic dermatitis	0.000104	0.00212	CbGpPWpGaD
Tolmetin—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000104	0.00199	CcSEcCtD
Tolmetin—Oedema—Triamcinolone—atopic dermatitis	0.000104	0.00199	CcSEcCtD
Tolmetin—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000104	0.00198	CcSEcCtD
Tolmetin—MPO—Selenium Micronutrient Network—TNF—atopic dermatitis	0.000103	0.0021	CbGpPWpGaD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000103	0.0021	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IFNG—atopic dermatitis	0.000103	0.00209	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—MAPK8—atopic dermatitis	0.000103	0.00208	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—IL6—atopic dermatitis	0.000102	0.00208	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—IL2—atopic dermatitis	0.000102	0.00206	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CCR5—atopic dermatitis	9.84e-05	0.002	CbGpPWpGaD
Tolmetin—Dyspepsia—Hydrocortisone—atopic dermatitis	9.76e-05	0.00186	CcSEcCtD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—CASP8—atopic dermatitis	9.66e-05	0.00196	CbGpPWpGaD
Tolmetin—Anaphylactic shock—Dexamethasone—atopic dermatitis	9.47e-05	0.0018	CcSEcCtD
Tolmetin—Oedema—Betamethasone—atopic dermatitis	9.47e-05	0.0018	CcSEcCtD
Tolmetin—Oedema—Dexamethasone—atopic dermatitis	9.47e-05	0.0018	CcSEcCtD
Tolmetin—Anaphylactic shock—Betamethasone—atopic dermatitis	9.47e-05	0.0018	CcSEcCtD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IL1B—atopic dermatitis	9.39e-05	0.00191	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IFNG—atopic dermatitis	9.37e-05	0.0019	CbGpPWpGaD
Tolmetin—PTGS2—Fluticasone Propionate—Methylprednisolone—atopic dermatitis	9.36e-05	0.0369	CbGdCrCtD
Tolmetin—CXCL8—Corticotropin-releasing hormone—MAPK8—atopic dermatitis	9.35e-05	0.0019	CbGpPWpGaD
Tolmetin—Thrombocytopenia—Dexamethasone—atopic dermatitis	9.27e-05	0.00177	CcSEcCtD
Tolmetin—Thrombocytopenia—Betamethasone—atopic dermatitis	9.27e-05	0.00177	CcSEcCtD
Tolmetin—PTGS2—Overview of nanoparticle effects—IL6—atopic dermatitis	9.24e-05	0.00188	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—CCL5—atopic dermatitis	9.22e-05	0.00187	CbGpPWpGaD
Tolmetin—PTGS2—Fluticasone Propionate—Betamethasone—atopic dermatitis	9.22e-05	0.0363	CbGdCrCtD
Tolmetin—PTGS2—Fluticasone Propionate—Dexamethasone—atopic dermatitis	9.22e-05	0.0363	CbGdCrCtD
Tolmetin—Dyspepsia—Triamcinolone—atopic dermatitis	9.19e-05	0.00175	CcSEcCtD
Tolmetin—CXCL8—GPCR ligand binding—CCR3—atopic dermatitis	9.18e-05	0.00186	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IL1B—atopic dermatitis	9.17e-05	0.00186	CbGpPWpGaD
Tolmetin—Dyspepsia—Methylprednisolone—atopic dermatitis	9.17e-05	0.00175	CcSEcCtD
Tolmetin—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	9.07e-05	0.00173	CcSEcCtD
Tolmetin—Urticaria—Prednisolone—atopic dermatitis	9.02e-05	0.00172	CcSEcCtD
Tolmetin—PTGS2—Fluticasone Propionate—Triamcinolone—atopic dermatitis	9e-05	0.0355	CbGdCrCtD
Tolmetin—CXCL8—Signaling by GPCR—CCL22—atopic dermatitis	8.96e-05	0.00182	CbGpPWpGaD
Tolmetin—Urticaria—Hydrocortisone—atopic dermatitis	8.81e-05	0.00168	CcSEcCtD
Tolmetin—CXCL8—GPCR downstream signaling—CCL27—atopic dermatitis	8.8e-05	0.00179	CbGpPWpGaD
Tolmetin—Body temperature increased—Hydrocortisone—atopic dermatitis	8.76e-05	0.00167	CcSEcCtD
Tolmetin—Abdominal pain—Hydrocortisone—atopic dermatitis	8.76e-05	0.00167	CcSEcCtD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—MAPK8—atopic dermatitis	8.61e-05	0.00175	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—IL6—atopic dermatitis	8.52e-05	0.00173	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	8.52e-05	0.00162	CcSEcCtD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	8.51e-05	0.00173	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—TNF—atopic dermatitis	8.36e-05	0.0017	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL1B—atopic dermatitis	8.36e-05	0.0017	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—IL6—atopic dermatitis	8.34e-05	0.00169	CbGpPWpGaD
Tolmetin—Dyspepsia—Dexamethasone—atopic dermatitis	8.34e-05	0.00159	CcSEcCtD
Tolmetin—Dyspepsia—Betamethasone—atopic dermatitis	8.34e-05	0.00159	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—IL2—atopic dermatitis	8.32e-05	0.00169	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—CCR5—atopic dermatitis	8.3e-05	0.00169	CbGpPWpGaD
Tolmetin—Urticaria—Triamcinolone—atopic dermatitis	8.29e-05	0.00158	CcSEcCtD
Tolmetin—Urticaria—Methylprednisolone—atopic dermatitis	8.27e-05	0.00158	CcSEcCtD
Tolmetin—Body temperature increased—Triamcinolone—atopic dermatitis	8.25e-05	0.00157	CcSEcCtD
Tolmetin—Anaphylactic shock—Prednisone—atopic dermatitis	8.25e-05	0.00157	CcSEcCtD
Tolmetin—Oedema—Prednisone—atopic dermatitis	8.25e-05	0.00157	CcSEcCtD
Tolmetin—Abdominal pain—Methylprednisolone—atopic dermatitis	8.23e-05	0.00157	CcSEcCtD
Tolmetin—CXCL8—GPCR ligand binding—NPS—atopic dermatitis	8.18e-05	0.00166	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—TAC1—atopic dermatitis	8.18e-05	0.00166	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—atopic dermatitis	8.16e-05	0.00166	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CXCL10—atopic dermatitis	8.14e-05	0.00165	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CXCR3—atopic dermatitis	8.02e-05	0.00163	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCL27—atopic dermatitis	7.99e-05	0.00162	CbGpPWpGaD
Tolmetin—Asthenia—Hydrocortisone—atopic dermatitis	7.95e-05	0.00152	CcSEcCtD
Tolmetin—CXCL8—Metabolism of proteins—CMA1—atopic dermatitis	7.92e-05	0.00161	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Dexamethasone—atopic dermatitis	7.74e-05	0.00148	CcSEcCtD
Tolmetin—Gastrointestinal pain—Betamethasone—atopic dermatitis	7.74e-05	0.00148	CcSEcCtD
Tolmetin—Diarrhoea—Hydrocortisone—atopic dermatitis	7.59e-05	0.00145	CcSEcCtD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—atopic dermatitis	7.58e-05	0.00154	CbGpPWpGaD
Tolmetin—Urticaria—Betamethasone—atopic dermatitis	7.52e-05	0.00143	CcSEcCtD
Tolmetin—Urticaria—Dexamethasone—atopic dermatitis	7.52e-05	0.00143	CcSEcCtD
Tolmetin—Dizziness—Prednisolone—atopic dermatitis	7.51e-05	0.00143	CcSEcCtD
Tolmetin—Asthenia—Triamcinolone—atopic dermatitis	7.49e-05	0.00143	CcSEcCtD
Tolmetin—Abdominal pain—Dexamethasone—atopic dermatitis	7.49e-05	0.00143	CcSEcCtD
Tolmetin—Body temperature increased—Dexamethasone—atopic dermatitis	7.49e-05	0.00143	CcSEcCtD
Tolmetin—Body temperature increased—Betamethasone—atopic dermatitis	7.49e-05	0.00143	CcSEcCtD
Tolmetin—Abdominal pain—Betamethasone—atopic dermatitis	7.49e-05	0.00143	CcSEcCtD
Tolmetin—Asthenia—Methylprednisolone—atopic dermatitis	7.47e-05	0.00142	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—IL6—atopic dermatitis	7.43e-05	0.00151	CbGpPWpGaD
Tolmetin—Dizziness—Hydrocortisone—atopic dermatitis	7.33e-05	0.0014	CcSEcCtD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL1B—atopic dermatitis	7.33e-05	0.00149	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	7.33e-05	0.00149	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—BDNF—atopic dermatitis	7.31e-05	0.00149	CbGpPWpGaD
Tolmetin—Dyspepsia—Prednisone—atopic dermatitis	7.26e-05	0.00138	CcSEcCtD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—atopic dermatitis	7.25e-05	0.00147	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCL17—atopic dermatitis	7.17e-05	0.00146	CbGpPWpGaD
Tolmetin—Diarrhoea—Methylprednisolone—atopic dermatitis	7.13e-05	0.00136	CcSEcCtD
Tolmetin—Headache—Prednisolone—atopic dermatitis	7.11e-05	0.00136	CcSEcCtD
Tolmetin—Constipation—Prednisone—atopic dermatitis	7.05e-05	0.00134	CcSEcCtD
Tolmetin—Vomiting—Hydrocortisone—atopic dermatitis	7.05e-05	0.00134	CcSEcCtD
Tolmetin—Headache—Hydrocortisone—atopic dermatitis	6.94e-05	0.00132	CcSEcCtD
Tolmetin—Dizziness—Triamcinolone—atopic dermatitis	6.9e-05	0.00132	CcSEcCtD
Tolmetin—Dizziness—Methylprednisolone—atopic dermatitis	6.89e-05	0.00131	CcSEcCtD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TNF—atopic dermatitis	6.81e-05	0.00138	CbGpPWpGaD
Tolmetin—Asthenia—Dexamethasone—atopic dermatitis	6.8e-05	0.00129	CcSEcCtD
Tolmetin—Asthenia—Betamethasone—atopic dermatitis	6.8e-05	0.00129	CcSEcCtD
Tolmetin—PTGS2—Spinal Cord Injury—IL4—atopic dermatitis	6.79e-05	0.00138	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Prednisone—atopic dermatitis	6.74e-05	0.00129	CcSEcCtD
Tolmetin—Nausea—Prednisolone—atopic dermatitis	6.74e-05	0.00128	CcSEcCtD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—MAPK8—atopic dermatitis	6.72e-05	0.00137	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	6.68e-05	0.00136	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	6.67e-05	0.00136	CbGpPWpGaD
Tolmetin—Vomiting—Triamcinolone—atopic dermatitis	6.64e-05	0.00126	CcSEcCtD
Tolmetin—Vomiting—Methylprednisolone—atopic dermatitis	6.62e-05	0.00126	CcSEcCtD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	6.6e-05	0.00134	CbGpPWpGaD
Tolmetin—Nausea—Hydrocortisone—atopic dermatitis	6.58e-05	0.00125	CcSEcCtD
Tolmetin—Urticaria—Prednisone—atopic dermatitis	6.55e-05	0.00125	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL6—atopic dermatitis	6.55e-05	0.00133	CbGpPWpGaD
Tolmetin—Headache—Triamcinolone—atopic dermatitis	6.54e-05	0.00125	CcSEcCtD
Tolmetin—PTGS1—Selenium Micronutrient Network—IFNG—atopic dermatitis	6.54e-05	0.00133	CbGpPWpGaD
Tolmetin—Headache—Methylprednisolone—atopic dermatitis	6.52e-05	0.00124	CcSEcCtD
Tolmetin—Abdominal pain—Prednisone—atopic dermatitis	6.52e-05	0.00124	CcSEcCtD
Tolmetin—Body temperature increased—Prednisone—atopic dermatitis	6.52e-05	0.00124	CcSEcCtD
Tolmetin—CXCL8—GPCR ligand binding—CXCL10—atopic dermatitis	6.48e-05	0.00132	CbGpPWpGaD
Tolmetin—Diarrhoea—Dexamethasone—atopic dermatitis	6.48e-05	0.00123	CcSEcCtD
Tolmetin—Diarrhoea—Betamethasone—atopic dermatitis	6.48e-05	0.00123	CcSEcCtD
Tolmetin—Dizziness—Dexamethasone—atopic dermatitis	6.26e-05	0.00119	CcSEcCtD
Tolmetin—Dizziness—Betamethasone—atopic dermatitis	6.26e-05	0.00119	CcSEcCtD
Tolmetin—Nausea—Triamcinolone—atopic dermatitis	6.2e-05	0.00118	CcSEcCtD
Tolmetin—Nausea—Methylprednisolone—atopic dermatitis	6.19e-05	0.00118	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—TNF—atopic dermatitis	6.06e-05	0.00123	CbGpPWpGaD
Tolmetin—Vomiting—Dexamethasone—atopic dermatitis	6.02e-05	0.00115	CcSEcCtD
Tolmetin—Vomiting—Betamethasone—atopic dermatitis	6.02e-05	0.00115	CcSEcCtD
Tolmetin—Headache—Betamethasone—atopic dermatitis	5.93e-05	0.00113	CcSEcCtD
Tolmetin—Headache—Dexamethasone—atopic dermatitis	5.93e-05	0.00113	CcSEcCtD
Tolmetin—Asthenia—Prednisone—atopic dermatitis	5.92e-05	0.00113	CcSEcCtD
Tolmetin—PTGS1—Selenium Micronutrient Network—IL1B—atopic dermatitis	5.83e-05	0.00118	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCL11—atopic dermatitis	5.78e-05	0.00117	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FCER2—atopic dermatitis	5.7e-05	0.00116	CbGpPWpGaD
Tolmetin—Diarrhoea—Prednisone—atopic dermatitis	5.64e-05	0.00108	CcSEcCtD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	5.64e-05	0.00115	CbGpPWpGaD
Tolmetin—Nausea—Betamethasone—atopic dermatitis	5.63e-05	0.00107	CcSEcCtD
Tolmetin—Nausea—Dexamethasone—atopic dermatitis	5.63e-05	0.00107	CcSEcCtD
Tolmetin—CXCL8—GPCR ligand binding—CCL5—atopic dermatitis	5.58e-05	0.00113	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IL6—atopic dermatitis	5.5e-05	0.00112	CbGpPWpGaD
Tolmetin—Dizziness—Prednisone—atopic dermatitis	5.45e-05	0.00104	CcSEcCtD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IL6—atopic dermatitis	5.37e-05	0.00109	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL6—atopic dermatitis	5.37e-05	0.00109	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—MAPK8—atopic dermatitis	5.32e-05	0.00108	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—atopic dermatitis	5.32e-05	0.00108	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	5.3e-05	0.00108	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCL22—atopic dermatitis	5.3e-05	0.00108	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—atopic dermatitis	5.28e-05	0.00107	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	5.25e-05	0.00107	CbGpPWpGaD
Tolmetin—Vomiting—Prednisone—atopic dermatitis	5.24e-05	0.000999	CcSEcCtD
Tolmetin—PTGS2—C-MYB transcription factor network—CD4—atopic dermatitis	5.2e-05	0.00106	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IFNG—atopic dermatitis	5.19e-05	0.00105	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CCR3—atopic dermatitis	5.19e-05	0.00105	CbGpPWpGaD
Tolmetin—Headache—Prednisone—atopic dermatitis	5.17e-05	0.000985	CcSEcCtD
Tolmetin—CXCL8—GPCR ligand binding—CCR5—atopic dermatitis	5.03e-05	0.00102	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	4.97e-05	0.00101	CbGpPWpGaD
Tolmetin—Nausea—Prednisone—atopic dermatitis	4.9e-05	0.000934	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—IL6—atopic dermatitis	4.89e-05	0.000994	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—TNF—atopic dermatitis	4.85e-05	0.000985	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCL27—atopic dermatitis	4.72e-05	0.000959	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCR3—atopic dermatitis	4.71e-05	0.000957	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL1B—atopic dermatitis	4.63e-05	0.00094	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—TAC1—atopic dermatitis	4.62e-05	0.000939	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—NPS—atopic dermatitis	4.62e-05	0.000939	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CXCR3—atopic dermatitis	4.53e-05	0.000921	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PPARA—atopic dermatitis	4.49e-05	0.000911	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IL5—atopic dermatitis	4.3e-05	0.000873	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL6—atopic dermatitis	4.29e-05	0.000872	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCL17—atopic dermatitis	4.23e-05	0.00086	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—TNF—atopic dermatitis	4.23e-05	0.00086	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—NPS—atopic dermatitis	4.2e-05	0.000853	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—TAC1—atopic dermatitis	4.2e-05	0.000853	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CXCR3—atopic dermatitis	4.12e-05	0.000836	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IFNG—atopic dermatitis	4.1e-05	0.000834	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—MAPK8—atopic dermatitis	4.02e-05	0.000817	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL6—atopic dermatitis	3.91e-05	0.000795	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL5—atopic dermatitis	3.9e-05	0.000793	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CXCL8—atopic dermatitis	3.82e-05	0.000775	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KIF3A—atopic dermatitis	3.77e-05	0.000767	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CXCL10—atopic dermatitis	3.66e-05	0.000744	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL1B—atopic dermatitis	3.66e-05	0.000744	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL2—atopic dermatitis	3.65e-05	0.000741	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	3.64e-05	0.00074	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IL6—atopic dermatitis	3.41e-05	0.000694	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCL11—atopic dermatitis	3.41e-05	0.000693	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CMA1—atopic dermatitis	3.41e-05	0.000693	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—IL6—atopic dermatitis	3.4e-05	0.000691	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—TNF—atopic dermatitis	3.36e-05	0.000682	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CXCL10—atopic dermatitis	3.33e-05	0.000676	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	3.28e-05	0.000667	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—STAT6—atopic dermatitis	3.21e-05	0.000652	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CCL5—atopic dermatitis	3.15e-05	0.000641	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GLB1—atopic dermatitis	2.97e-05	0.000604	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCL5—atopic dermatitis	2.86e-05	0.000582	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ADSL—atopic dermatitis	2.85e-05	0.000579	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CCR5—atopic dermatitis	2.84e-05	0.000577	CbGpPWpGaD
Tolmetin—PTGS2—Disease—GLB1—atopic dermatitis	2.82e-05	0.000572	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCR3—atopic dermatitis	2.78e-05	0.000565	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL6—atopic dermatitis	2.71e-05	0.000551	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TNF—atopic dermatitis	2.66e-05	0.00054	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCR5—atopic dermatitis	2.58e-05	0.000524	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—IL6—atopic dermatitis	2.57e-05	0.000522	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.54e-05	0.000517	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NPS—atopic dermatitis	2.48e-05	0.000504	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TAC1—atopic dermatitis	2.48e-05	0.000504	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CXCR3—atopic dermatitis	2.43e-05	0.000494	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GLB1—atopic dermatitis	2.36e-05	0.000479	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL5—atopic dermatitis	2.3e-05	0.000468	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.28e-05	0.000464	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ADSL—atopic dermatitis	2.26e-05	0.000459	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.17e-05	0.00044	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL6—atopic dermatitis	2.14e-05	0.000435	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CXCL10—atopic dermatitis	1.97e-05	0.000399	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SLC11A1—atopic dermatitis	1.89e-05	0.000383	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.81e-05	0.000367	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.72e-05	0.000349	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCL5—atopic dermatitis	1.69e-05	0.000344	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IL2—atopic dermatitis	1.64e-05	0.000334	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NGF—atopic dermatitis	1.57e-05	0.000318	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCR5—atopic dermatitis	1.52e-05	0.00031	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL2—atopic dermatitis	1.49e-05	0.000303	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NFKBIA—atopic dermatitis	1.29e-05	0.000263	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PPARA—atopic dermatitis	9.64e-06	0.000196	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CCR5—atopic dermatitis	9.53e-06	0.000194	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL2—atopic dermatitis	8.81e-06	0.000179	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL6—atopic dermatitis	8.76e-06	0.000178	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAPK8—atopic dermatitis	8.11e-06	0.000165	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PPARA—atopic dermatitis	7.65e-06	0.000156	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD4—atopic dermatitis	5.99e-06	0.000122	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6—atopic dermatitis	5.18e-06	0.000105	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6—atopic dermatitis	3.24e-06	6.58e-05	CbGpPWpGaD
